• Molecular NameOxandrolone
  • SynonymOssandrolone [DCIT]; Oxandrolona [INN-Spanish]; oxandrolone; Oxandrolonum [INN-Latin]
  • Weight306.446
  • Drugbank_IDDB00621
  • ACS_NO53-39-4
  • Show 3D model
  • LogP (experiment)3.073
  • LogP (predicted, AB/LogP v2.0)2.84
  • pkaN/A
  • LogD (pH=7, predicted)2.84
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-3.74
  • LogSw (predicted, AB/LogsW2.0)0.02
  • Sw (mg/ml) (predicted, ACD/Labs)0.06
  • No.of HBond Donors1
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds0
  • TPSA46.53
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyThe drug was prescribed to promote muscle regrowth in disorders which cause involuntary weight loss. It had also been shown to be partially successful in treating cases of osteoporosis.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability97.0
  • Protein binding95.5
  • Volume of distribution (VD)578 mL/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half lifeBiphasic plasma elimination: from 90 min to 4 h, and 33 min, and from 4 to 48 h, and 9 h.
  • ExcretionUrinary:90%; Fecal:6%
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A